1. Home
  2. MSS
  3. MSS News

Latest Maison Solutions Inc. (MSS) News on November 15, 2024

Maison Solutions Completes El Monte Store Renovation
MSS

ACCESSWIRE

18 days ago

Maison Solutions Completes El Monte Store Renovation

MSS

MT Newswires

2 months ago

Sector Update: Consumer Stocks Mixed Premarket Tuesday

MSS

MT Newswires

2 months ago

Sector Update: Consumer

Maison Solutions Reports First Quarter 2025 Financial Results
MSS

ACCESSWIRE

2 months ago

Maison Solutions Reports First Quarter 2025 Financial Results

Maison Solutions Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.078 profit in FY 2023)
MSS

Simply Wall St.

3 months ago

Maison Solutions Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.078 profit in FY 2023)

MSS

ACCESSWIRE

3 months ago

Maison Solutions Reports Full Year 2024 Financial Results

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
MSS

GuruFocus.com

5 months ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Where Will DocuSign Stock Be in 1 Year?
MSS

Motley Fool

5 months ago

Where Will DocuSign Stock Be in 1 Year?

MSS

Energy Global

5 months ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

**Canadian Interest in American Whiskey Peaks Ahead of Bourbon Day**
MSS

CNW Group

5 months ago

**Canadian Interest in American Whiskey Peaks Ahead of Bourbon Day**

Poppulo Joins Elite Category in BrightSign Bright Alliance Program, Announces Certification Across Series 5 Devices
MSS

GlobeNewswire

5 months ago

Poppulo Joins Elite Category in BrightSign Bright Alliance Program, Announces Certification Across Series 5 Devices

Spotify to introduce expensive plan later this year, Bloomberg News reports
MSS

Reuters

5 months ago

Spotify to introduce expensive plan later this year, Bloomberg News reports

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
MSS

USA TODAY

5 months ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
MSS

Business Wire

5 months ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Maison Solutions Releases Post-Acquisition Webinar Detailing Recent Expansion into Arizona
MSS

ACCESSWIRE

7 months ago

Maison Solutions Releases Post-Acquisition Webinar Detailing Recent Expansion into Arizona

Maison Solutions to Share Additional Details Regarding Expansion into Arizona on Friday, April 19, 2024 at 11:00 a.m. ET
MSS

ACCESSWIRE

7 months ago

Maison Solutions to Share Additional Details Regarding Expansion into Arizona on Friday, April 19, 2024 at 11:00 a.m. ET

Maison Solutions Expands into Arizona with Acquisition of Three-Store Lee Lee International Supermarkets Chain
MSS

ACCESSWIRE

7 months ago

Maison Solutions Expands into Arizona with Acquisition of Three-Store Lee Lee International Supermarkets Chain

Maison Solutions buys Arizona grocer for $22M
MSS

Grocery Dive

7 months ago

Maison Solutions buys Arizona grocer for $22M

Maison Solutions Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results
MSS

ACCESSWIRE

8 months ago

Maison Solutions Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results

Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now
MSS

GlobeNewswire

9 months ago

Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now

Maison Solutions Launches Store Renovation Program
MSS

ACCESSWIRE

10 months ago

Maison Solutions Launches Store Renovation Program

Duos RIP® Scans Over Eight and a Half Million Railcars in ‘23
MSS

GlobeNewswire

10 months ago

Duos RIP® Scans Over Eight and a Half Million Railcars in ‘23

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010
MSS

GlobeNewswire

10 months ago

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

Maison Solutions to Present at Emerging Growth Conference
MSS

ACCESSWIRE

10 months ago

Maison Solutions to Present at Emerging Growth Conference

D-Wave Becomes First Full-Stack Quantum Provider to Achieve SOC 2 Type 2 Compliance
MSS

NewMediaWire

10 months ago

D-Wave Becomes First Full-Stack Quantum Provider to Achieve SOC 2 Type 2 Compliance

Sphere 3D Corp. Provides December 2023 Production and Operation Updates
MSS

Newsfile

10 months ago

Sphere 3D Corp. Provides December 2023 Production and Operation Updates

Trinity Capital Inc. Announces Adjustment to Conversion Rate of its 6.00% Convertible Notes due 2025
MSS

PR Newswire

a year ago

Trinity Capital Inc. Announces Adjustment to Conversion Rate of its 6.00% Convertible Notes due 2025

NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
MSS

GlobeNewswire

a year ago

NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU
MSS

GlobeNewswire

a year ago

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU

These Stocks under $10 Are Poised To Explode
MSS

Insider Monkey

a year ago

These Stocks under $10 Are Poised To Explode

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
MSS

GlobeNewswire

a year ago

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury

Maison Solutions Issues Statement Regarding Short Attack on its Securities
MSS

ACCESSWIRE

a year ago

Maison Solutions Issues Statement Regarding Short Attack on its Securities

Maison Solutions Reports Fiscal 2024 Second Quarter and Six-Month Financial Results
MSS

ACCESSWIRE

a year ago

Maison Solutions Reports Fiscal 2024 Second Quarter and Six-Month Financial Results

Stronghold Digital Mining, Inc. (NASDAQ:SDIG) Stock Rockets 26% But Many Are Still Ignoring The Company
MSS

Simply Wall St.

a year ago

Stronghold Digital Mining, Inc. (NASDAQ:SDIG) Stock Rockets 26% But Many Are Still Ignoring The Company

Sphere 3D Corp. (NASDAQ:ANY) Soars 53% But It's A Story Of Risk Vs Reward
MSS

Simply Wall St.

a year ago

Sphere 3D Corp. (NASDAQ:ANY) Soars 53% But It's A Story Of Risk Vs Reward

Innate Pharma Announces Leadership Change
MSS

Business Wire

a year ago

Innate Pharma Announces Leadership Change

Reneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Study
MSS

Zacks

a year ago

Reneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Study

REPAY Partners with Green Dot to Expand Cash Bill Pay Innovations for Consumers and Businesses
MSS

Business Wire

a year ago

REPAY Partners with Green Dot to Expand Cash Bill Pay Innovations for Consumers and Businesses

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
MSS

GlobeNewswire

a year ago

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

Sonder Holdings Inc. Appoints Tom Buoy as Executive Vice President and Chief Commercial Officer
MSS

Business Wire

a year ago

Sonder Holdings Inc. Appoints Tom Buoy as Executive Vice President and Chief Commercial Officer

Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
MSS

Business Wire

a year ago

Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023

MSS

Associated Press Finance

a year ago

Delta Apparel: Fiscal Q4 Earnings Snapshot

Delta Apparel Reports Fourth Quarter and Full Year Fiscal 2023 Results
MSS

Business Wire

a year ago

Delta Apparel Reports Fourth Quarter and Full Year Fiscal 2023 Results

Amazfit launches "Wellness Wonderland" in collaboration with the Siciliano Contemporary Ballet to promote wellness this holiday season
MSS

Business Wire

a year ago

Amazfit launches "Wellness Wonderland" in collaboration with the Siciliano Contemporary Ballet to promote wellness this holiday season

Rand Capital Declares Total Fourth Quarter Cash Dividend of $0.63 per Share; Full Year 2023 Dividend Distributions up 60%
MSS

Business Wire

a year ago

Rand Capital Declares Total Fourth Quarter Cash Dividend of $0.63 per Share; Full Year 2023 Dividend Distributions up 60%

Delta Apparel Announces Reporting Date for Fiscal 2023 Fourth Quarter and Year-End Results
MSS

Business Wire

a year ago

Delta Apparel Announces Reporting Date for Fiscal 2023 Fourth Quarter and Year-End Results

Maison Solutions Closes Private Placement
MSS

ACCESSWIRE

a year ago

Maison Solutions Closes Private Placement

ACCESSWIRE’s Press Release Optimizer Gives Brands the Visibility Boost they Need to Stand Out
MSS

ACCESSWIRE

a year ago

ACCESSWIRE’s Press Release Optimizer Gives Brands the Visibility Boost they Need to Stand Out

MSS

InvestorPlace

a year ago

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
MSS

GlobeNewswire

a year ago

Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

Connect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis
MSS

GlobeNewswire

a year ago

Connect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of October 2023
MSS

GlobeNewswire

a year ago

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of October 2023

MSS

GlobeNewswire

a year ago

UCLOUDLINK GROUP INC. Announces Unaudited Third Quarter 2023 Financial Results

FreightCar America, Trinity Industries take hit from migrant crossings
MSS

FreightWaves

a year ago

FreightCar America, Trinity Industries take hit from migrant crossings

FreightCar America, Inc. (NASDAQ:RAIL) Q3 2023 Earnings Call Transcript
MSS

Insider Monkey

a year ago

FreightCar America, Inc. (NASDAQ:RAIL) Q3 2023 Earnings Call Transcript

CPI Aero Receives $9.6 Million Purchase Orders From U.S. Air Force for T-38 Aircraft Modification Kits
MSS

GlobeNewswire

a year ago

CPI Aero Receives $9.6 Million Purchase Orders From U.S. Air Force for T-38 Aircraft Modification Kits

Arbutus to Present at Jefferies London Healthcare Conference
MSS

GlobeNewswire

a year ago

Arbutus to Present at Jefferies London Healthcare Conference

MSS

GlobeNewswire

a year ago

UCLOUDLINK GROUP INC. to Report Third Quarter 2023 Financial Results on November 15, 2023

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
MSS

Business Wire

a year ago

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Carbon Revolution Begins Trading on Nasdaq Under CREV
MSS

IPO-Edge.com

a year ago

Carbon Revolution Begins Trading on Nasdaq Under CREV

Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors
MSS

GlobeNewswire

a year ago

Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors

Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
MSS

GlobeNewswire

a year ago

Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Share on Social Networks: